Dual-Target Universal CAR-T Cell Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual-Target Universal CAR-T Cell Therapy, covering 2026-03-02 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus [Phase 1]